Recall Register

Drug recall: Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles…

Class I FDA enforcement event 91259. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon started this drug recall on 6 Dec 2022. The firm address in the FDA record is in Warren, NJ. FDA put the recall in Class I. FDA event 91259 has 3 product records. The first FDA enforcement report date is 1 Feb 2023. The record gives the status Terminated, with the termination date 26 Feb 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA.

Recalling firm

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon, Warren, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 91259: product records
Recall numberProductQuantityClassStatusReport date
D-0181-2023Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940321,246 tabletsClass ITerminated1 Feb 2023
D-0182-2023Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 388,380 capsulesClass ITerminated1 Feb 2023
D-0183-2023Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5209,292 capsulesClass ITerminated1 Feb 2023

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2022
325
Share of these events in Class I
18%
Product records in this event
3
Events of the firm on the register
1

Official channels

Cite this page

Recall Register. FDA enforcement event 91259. https://recallregister.com/fda/i/91259/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA.
What quantity of product is in FDA event 91259?
The event has 3 product records. The first record gives this quantity: 321,246 tablets
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2022 have the same class?
18% of the 325 drug events that started in 2022 are in Class I.